Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex32-1.htm |
| 10-K - 10-K - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_10k.htm |
| EX-31.2 - EXHIBIT 31..2 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex23-1.htm |
| EX-21.1 - EXHIBIT 21.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex21-1.htm |
| EX-4.2 - EXHIBIT 4.2 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex4-2.htm |
Exhibit 22.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| 1. |
Registration Statement (Form S-3 No. 333-227398) of Chembio Diagnostics, Inc.,
|
| 2. |
Registration Statement (Form S-3 No. 333- 215813) of Chembio Diagnostics, Inc.,
|
| 3. |
Registration Statement (Form S-8 No. 333- 151785) pertaining to the 2008 Stock Incentive Plan of Chembio Diagnostics, Inc., and
|
| 4. |
Registration Statement (Form S-8 No. 333- 203633) pertaining to the 2014 Stock Incentive Plan and an employment agreement of Chembio Diagnostics, Inc.;
|
of our report dated March 11, 2021, with respect to the consolidated financial statements of Chembio Diagnostics, Inc, included in this Annual Report
(Form 10-K) of Chembio Diagnostics, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young, LLP
Jericho, New York
March 11, 2021